SCHEMBL21634673

SCHEMBL21634673

CCNCCOCCCCCCCCNCC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.41
EPHX2 P34913 5/20 0.38
CYP2C19 P33261 4/20 0.38
CYP1A2 P05177 2/20 0.38
KDM1A O60341 1/20 0.36
SAT1 P21673 1/20 0.36
PLA2G2C Q5R387 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MEN1 O00255 1/20 0.34
GLA P06280 1/20 0.34
KMT2A Q03164 1/20 0.34
CES2 O00748 1/20 0.33
ADRA1A P35348 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6916302 0.86 EPHX2 (0.50) EPHX2PLA2G2CALDH1A1MEN1KMT2A
SCHEMBL15974343 0.86 ALDH1A1 (0.41) EPHX2CYP2C19CYP1A2KDM1ASAT1
SCHEMBL3716700 0.86 ALDH1A1 (0.41) EPHX2CYP2C19CYP1A2KDM1ASAT1
SCHEMBL20634245 0.84 CYP2C19 (0.52) CYP2C19CYP1A2KDM1ASAT1ALDH1A1
SCHEMBL22749468 0.83 ALDH1A1 (0.47) EPHX2CYP2C19CYP1A2SAT1ALDH1A1
SCHEMBL30891500 0.82 CYP2C19 (0.52) LTA4HEPHX2CYP2C19CYP1A2KDM1A
SCHEMBL22749476 0.81 ALDH1A1 (0.44) EPHX2CYP2C19CYP1A2SAT1ALDH1A1
SCHEMBL7720909 0.80 ALDH1A1 (0.45) LTA4HEPHX2ALDH1A1CYP2D6ADRA1A
SCHEMBL13822544 0.80 CYP2C19 (0.57) EPHX2CYP2C19CYP1A2KDM1ASAT1
SCHEMBL22835027 0.79 GPR84 (0.55) EPHX2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3830093-A1 BIFUNCTIONAL COMPOUNDS AS CDK MODULATORS Biotheryx, Inc. (US) 2021-06-09 EP disclosed
WO-2020023782-A1 BIFUNCTIONAL COMPOUNDS AS CDK MODULATORS BIOTHERYX, INC. (US) 2020-01-30 WO disclosed